Showing results (141-150 of 2,365) with videos related to
Sort By:
Pageof 237
Plos Pathogens|May 14, 2009
Avian Influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airwaysMargaret A Scull, Laura Gillim-Ross, Celia Santos, et al.Med (New York, N.Y.)|September 28, 2023
Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 strains are dependent on serine proteases for entry throughout the human respiratory tractMatthew J Gartner, Leo Yi Yang Lee, Francesca L Mordant, et al.Expert Review of Vaccines|June 2, 2022
Nonhuman primate models for evaluation of SARS-CoV-2 vaccinesJessica A Neil, Maryanne Griffith, Dale I Godfrey, et al.Molecular Therapy. Nucleic Acids|March 20, 2026
Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenzaMai N Vu, Jessica A Neil, Charley Mackenzie-Kludas, et al.Mbio|June 1, 2017
In Vivo Imaging of Influenza Virus Infection in Immunized MiceRita Czakó, Leatrice Vogel, Elaine W Lamirande, et al.The Journal of Hospital Infection|May 26, 2026
Room-return ventilation and N95 respirator policies for reducing airborne pathogen exposure on hospital wardsCameron Zachreson, Xiangdong Li, Kevin Kevin, et al.Virology|December 31, 2002
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse geneticsKanta Subbarao, Hualan Chen, David Swayne, et al.Viral Immunology|October 2, 2010
Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccineAnjeanette Roberts, Elaine W Lamirande, Leatrice Vogel, et al.Clinical & Translational Immunology|May 16, 2022
Off-target effects of bacillus Calmette-Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19Nicole L Messina, Susie Germano, Rebecca McElroy, et al.Journal of Virology|October 20, 2017
In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in MiceTroy C Sutton, Elaine W Lamirande, Kevin W Bock, et al.Pageof 237